Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4100119
Max Phase: Preclinical
Molecular Formula: C21H18FN7O4
Molecular Weight: 451.42
Molecule Type: Small molecule
Associated Items:
ID: ALA4100119
Max Phase: Preclinical
Molecular Formula: C21H18FN7O4
Molecular Weight: 451.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nn(-c2ncnc3nc[nH]c23)c2c1C(OCc1cc(F)cc3c1OCOC3)CC(=O)N2
Standard InChI: InChI=1S/C21H18FN7O4/c1-10-16-14(32-6-12-3-13(22)2-11-5-31-9-33-18(11)12)4-15(30)27-20(16)29(28-10)21-17-19(24-7-23-17)25-8-26-21/h2-3,7-8,14H,4-6,9H2,1H3,(H,27,30)(H,23,24,25,26)
Standard InChI Key: GGHNDEIHCIKSNC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 451.42 | Molecular Weight (Monoisotopic): 451.1404 | AlogP: 2.45 | #Rotatable Bonds: 4 |
Polar Surface Area: 129.07 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.17 | CX Basic pKa: 2.08 | CX LogP: 1.20 | CX LogD: 1.19 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.48 | Np Likeness Score: -1.16 |
1. Frimurer TM, Mende F, Graae AS, Engelstoft MS, Egerod KL, Nygaard R, Gerlach LO, Hansen JB, Schwartz TW, Holst B.. (2017) Model-Based Discovery of Synthetic Agonists for the Zn2+-Sensing G-Protein-Coupled Receptor 39 (GPR39) Reveals Novel Biological Functions., 60 (3): [PMID:28045522] [10.1021/acs.jmedchem.6b00648] |
Source(1):